Document is current

Any future updates will be listed below

Late conversion from tacrolimus to a belatacept-based immuno-suppression regime in kidney transplant recipients improves renal function, acid-base derangement and mineral-bone metabolism

Crossref DOI link: https://doi.org/10.1007/s40620-017-0411-0

Published Online: 2017-05-24

Published Print: 2017-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark